Patent De­bate: Two In­dian Gener­ics Mak­ers End Battle

The Economic Times - - Companies -

Two In­dian drug­mak­ers said they had given up a battle to copy drugs de­vel­oped by Bris­tol My­ers Squibb and As­traZeneca, blam­ing a lack of gov­ern­ment sup­port for cheap gener­ics and pres­sure from Big Pharma. Both com­pa­nies, BDR Pharma and Lee Pharma, had been seek­ing so-called com­pul­sory li­censes that over­ride patents and al­low gener­ics firms in In­dia to launch cheap copies of medicines man­u­fac­tured by big Western drug­mak­ers. But now the two mid-sized gener­ics play­ers say their ef­forts have been thwarted by Prime Min­is­ter Naren­dra Modi's tar­get to boost for­eign in­vest­ment in In­dia.


Newspapers in English

Newspapers from India

© PressReader. All rights reserved.